vs

Side-by-side financial comparison of electroCore, Inc. (ECOR) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.

Electromed, Inc. is the larger business by last-quarter revenue ($18.9M vs $9.2M, roughly 2.0× electroCore, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs -32.8%, a 47.4% gap on every dollar of revenue. On growth, electroCore, Inc. posted the faster year-over-year revenue change (31.2% vs 16.3%). Over the past eight quarters, electroCore, Inc.'s revenue compounded faster (30.3% CAGR vs 16.7%).

electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.

Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.

ECOR vs ELMD — Head-to-Head

Bigger by revenue
ELMD
ELMD
2.0× larger
ELMD
$18.9M
$9.2M
ECOR
Growing faster (revenue YoY)
ECOR
ECOR
+14.9% gap
ECOR
31.2%
16.3%
ELMD
Higher net margin
ELMD
ELMD
47.4% more per $
ELMD
14.6%
-32.8%
ECOR
Faster 2-yr revenue CAGR
ECOR
ECOR
Annualised
ECOR
30.3%
16.7%
ELMD

Income Statement — Q4 2025 vs Q2 2026

Metric
ECOR
ECOR
ELMD
ELMD
Revenue
$9.2M
$18.9M
Net Profit
$-3.0M
$2.8M
Gross Margin
88.4%
78.4%
Operating Margin
-31.8%
19.2%
Net Margin
-32.8%
14.6%
Revenue YoY
31.2%
16.3%
Net Profit YoY
6.0%
40.3%
EPS (diluted)
$-0.34
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECOR
ECOR
ELMD
ELMD
Q4 25
$9.2M
$18.9M
Q3 25
$8.7M
$16.9M
Q2 25
$7.4M
$17.4M
Q1 25
$6.7M
$15.7M
Q4 24
$7.0M
$16.3M
Q3 24
$6.6M
$14.7M
Q2 24
$6.1M
$14.8M
Q1 24
$5.4M
$13.9M
Net Profit
ECOR
ECOR
ELMD
ELMD
Q4 25
$-3.0M
$2.8M
Q3 25
$-3.4M
$2.1M
Q2 25
$-3.7M
$2.2M
Q1 25
$-3.9M
$1.9M
Q4 24
$-3.2M
$2.0M
Q3 24
$-2.5M
$1.5M
Q2 24
$-2.7M
$1.8M
Q1 24
$-3.5M
$1.5M
Gross Margin
ECOR
ECOR
ELMD
ELMD
Q4 25
88.4%
78.4%
Q3 25
86.0%
78.1%
Q2 25
87.3%
78.3%
Q1 25
84.9%
78.0%
Q4 24
85.9%
77.7%
Q3 24
83.8%
78.3%
Q2 24
86.3%
76.2%
Q1 24
83.7%
74.8%
Operating Margin
ECOR
ECOR
ELMD
ELMD
Q4 25
-31.8%
19.2%
Q3 25
-33.2%
15.8%
Q2 25
-47.5%
17.5%
Q1 25
-56.9%
13.6%
Q4 24
-43.6%
15.6%
Q3 24
-40.4%
13.2%
Q2 24
-42.2%
15.7%
Q1 24
-70.7%
13.3%
Net Margin
ECOR
ECOR
ELMD
ELMD
Q4 25
-32.8%
14.6%
Q3 25
-39.2%
12.6%
Q2 25
-49.7%
12.7%
Q1 25
-57.4%
12.1%
Q4 24
-45.8%
12.1%
Q3 24
-38.1%
10.0%
Q2 24
-43.2%
12.3%
Q1 24
-64.4%
10.8%
EPS (diluted)
ECOR
ECOR
ELMD
ELMD
Q4 25
$-0.34
$0.32
Q3 25
$-0.40
$0.25
Q2 25
$-0.44
$0.26
Q1 25
$-0.47
$0.21
Q4 24
$-0.37
$0.22
Q3 24
$-0.31
$0.16
Q2 24
$-0.38
$0.20
Q1 24
$-0.53
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECOR
ECOR
ELMD
ELMD
Cash + ST InvestmentsLiquidity on hand
$11.6M
$13.8M
Total DebtLower is stronger
$7.8M
Stockholders' EquityBook value
$-1.7M
$45.4M
Total Assets
$18.7M
$54.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECOR
ECOR
ELMD
ELMD
Q4 25
$11.6M
$13.8M
Q3 25
$13.0M
$14.1M
Q2 25
$7.1M
$15.3M
Q1 25
$7.8M
$15.2M
Q4 24
$12.2M
$16.2M
Q3 24
$12.9M
$13.9M
Q2 24
$14.2M
$16.1M
Q1 24
$7.8M
$11.7M
Total Debt
ECOR
ECOR
ELMD
ELMD
Q4 25
$7.8M
Q3 25
$7.8M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ECOR
ECOR
ELMD
ELMD
Q4 25
$-1.7M
$45.4M
Q3 25
$-1.1M
$44.7M
Q2 25
$1.1M
$43.2M
Q1 25
$4.4M
$43.9M
Q4 24
$7.5M
$43.6M
Q3 24
$9.5M
$41.5M
Q2 24
$11.5M
$44.5M
Q1 24
$4.5M
$42.5M
Total Assets
ECOR
ECOR
ELMD
ELMD
Q4 25
$18.7M
$54.9M
Q3 25
$21.4M
$53.6M
Q2 25
$14.6M
$53.8M
Q1 25
$16.0M
$52.5M
Q4 24
$20.5M
$52.3M
Q3 24
$21.0M
$48.9M
Q2 24
$22.4M
$52.2M
Q1 24
$13.9M
$48.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECOR
ECOR
ELMD
ELMD
Operating Cash FlowLast quarter
$-1.5M
$3.0M
Free Cash FlowOCF − Capex
$2.4M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
0.0%
3.4%
Cash ConversionOCF / Net Profit
1.10×
TTM Free Cash FlowTrailing 4 quarters
$7.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECOR
ECOR
ELMD
ELMD
Q4 25
$-1.5M
$3.0M
Q3 25
$-1.7M
$169.0K
Q2 25
$-623.0K
$3.9M
Q1 25
$-4.4M
$2.1M
Q4 24
$-1.3M
$3.2M
Q3 24
$-1.4M
$2.3M
Q2 24
$-1.8M
$4.5M
Q1 24
$-2.6M
$1.4M
Free Cash Flow
ECOR
ECOR
ELMD
ELMD
Q4 25
$2.4M
Q3 25
$-1.7M
$-83.0K
Q2 25
$-648.0K
$3.7M
Q1 25
$-4.4M
$1.9M
Q4 24
$2.9M
Q3 24
$2.3M
Q2 24
$4.5M
Q1 24
$1.3M
FCF Margin
ECOR
ECOR
ELMD
ELMD
Q4 25
12.7%
Q3 25
-19.3%
-0.5%
Q2 25
-8.8%
21.4%
Q1 25
-65.4%
12.2%
Q4 24
18.0%
Q3 24
15.5%
Q2 24
30.1%
Q1 24
9.1%
Capex Intensity
ECOR
ECOR
ELMD
ELMD
Q4 25
0.0%
3.4%
Q3 25
0.0%
1.5%
Q2 25
0.3%
0.8%
Q1 25
0.6%
1.0%
Q4 24
1.4%
Q3 24
0.3%
Q2 24
0.1%
Q1 24
0.6%
Cash Conversion
ECOR
ECOR
ELMD
ELMD
Q4 25
1.10×
Q3 25
0.08×
Q2 25
1.75×
Q1 25
1.10×
Q4 24
1.60×
Q3 24
1.57×
Q2 24
2.46×
Q1 24
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons